AB036. Comparison of the effectiveness of gefitinib, erlotinib and afatinib in epidermal growth factor receptor mutated tumors of non-small cell lung cancer

Maria Papathanasiou, Sofia Lambaki, Konstantinos Porpodis, Dionysios Spyratos, Stayros Tryfon, Paulos Zarogoulidis, Ellada Eleytheriadoy, Theodoros Kontakiotis